NCT04644276

Brief Summary

To reduce interface leak and aerosol spread, Philips has developed an accessory to non-invasive ventilation(NIV) masks to be used with the Philips AF531 and the PerformaTrak mask on respiratory failure patients. For the purposes of capturing initial mask leak and safety data, this trial will enroll patients treated with NIV in an institutional setting (i.e., sleep lab).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 18, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 25, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

February 17, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 9, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 9, 2021

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

May 26, 2023

Completed
Last Updated

May 26, 2023

Status Verified

May 1, 2023

Enrollment Period

10 months

First QC Date

November 18, 2020

Results QC Date

December 8, 2022

Last Update Submit

May 24, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Medical Adhesive-Related Skin Injury (MARSI)

    Percentage of patients who have severe and extreme skin irritation that persists for ≥ 30 min after mask adhesive removal (score of ≥ 3 on a 5-point grading system).

    Up to 5 business days

  • Clinician Ease of Use

    Clinician-perceived mask adhesive ease-of-use as measured by a 0-10 Likert Scale at baseline (initial impressions) and study completion (overall impressions) Specifically, the item, "How would you rate the ease of application of the adhesive to the mask?" (On a 0 to 10 scale, with 0=Extremely Difficult and 10=Extremely Easy)

    Initial Impressions at Baseline and Overall Impressions at Study Completion (After at least two mask applications)

Secondary Outcomes (1)

  • Leak Change

    Up to 5 business days

Study Arms (2)

Mask with Mask Adhesive/Arm 1

ACTIVE COMPARATOR

Patients will be randomized to AF531 if they receive mask adhesive with mask on the first study night then the mask without mask adhesive(Performatrak) on the second study night.

Device: Mask with Mask Adhesive/Arm 1

Mask without Mask Adhesive/Arm 2

PLACEBO COMPARATOR

Patients will be randomized to Arm 2 if they receive the mask without mask adhesive on the first study night then they will receive the mask with the mask adhesive on the second study night.

Device: Mask without Mask Adhesive / Arm 2

Interventions

Patients will be randomized to Arm1 if they receive the mask adhesive and mask on the first study night then the mask without the mask adhesive on the second study night.

Mask with Mask Adhesive/Arm 1

Patients will be randomized to Arm 2 if they receive the mask without mask adhesive on the first study night then the mask adhesive with the mask on the second study night.

Mask without Mask Adhesive/Arm 2

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults patients age 18 to 85 (inclusive)
  • Adult patients treated with NIV
  • Able to read, write, and speak English
  • Able to provide written informed consent
  • Willing to have facial hair removed for adhesive placement (if required)

You may not qualify if:

  • Pre-existing allergy to tape or adhesive;
  • Blisters, open skin or pre-existing skin condition that may impact the ability to support removal of the mask adhesive without tearing the skin
  • pregnant (for females of childbearing age);
  • Individuals sentenced to such an institution under a criminal or civil statute,
  • Individuals detained in other facilities by virtue of statutes or commitment procedures which provide alternatives to criminal prosecution or incarceration in a penal institution, and individuals detained pending arraignment, trial, or sentencing

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sleep Disorder Center of Alabama

Birmingham, Alabama, 35213, United States

Location

MeSH Terms

Conditions

Respiratory InsufficiencyCOVID-19

Interventions

Masks

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung Diseases

Intervention Hierarchy (Ancestors)

Surgical AttireEquipment and Supplies, HospitalEquipment and SuppliesProtective DevicesPersonal Protective EquipmentSurgical EquipmentManufactured MaterialsTechnology, Industry, and Agriculture

Results Point of Contact

Title
Chuck Cain
Organization
Philips

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 18, 2020

First Posted

November 25, 2020

Study Start

February 17, 2021

Primary Completion

December 9, 2021

Study Completion

December 9, 2021

Last Updated

May 26, 2023

Results First Posted

May 26, 2023

Record last verified: 2023-05

Locations